Purple Biotech Ltd.PPBTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank64
3Y CAGR-15.0%
5Y CAGR+4.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-15.0%/yr
vs +10.4%/yr prior
5Y CAGR
+4.7%/yr
Recent deceleration
Acceleration
-25.4pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $11.01M | +149.0% |
| 2023 | $-22.47M | -199.4% |
| 2022 | $22.60M | +26.0% |
| 2021 | $17.93M | +35.5% |
| 2020 | $13.24M | +51.3% |
| 2019 | $8.75M | -0.8% |
| 2018 | $8.83M | -26.8% |
| 2017 | $12.06M | +67.9% |
| 2016 | $7.18M | +76.5% |
| 2015 | $4.07M | - |